E. Gough, M. C. Kempf, L. Graham, M. Manzanero, E. W. Hook et al., HIV and hepatitis B and C incidence rates in US correctional populations and high-risk groups: a systematic review and metaanalysis, BMC Public Health, vol.10, p.21176146, 2010.

L. Michel, C. Lions, S. Van-malderen, J. Schiltz, W. Vanderplasschen et al., Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concern, BMC Public Health, vol.15, p.26507505, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01264470

P. Roux, L. Sagaon-teyssier, C. Lions, L. Fugon, P. Verger et al., HCV seropositivity in inmates and in the general population: an averaging approach to establish priority prevention interventions, BMJ Open, vol.4, p.25331969, 2014.

D. Daniel, D. J. Francois, and Y. Patrick, Prise en charge thérapeutique et suivi de l'ensemble des personnes infectées par le virus de l'hé patite C: rapport de recommandations, 2016.

M. Rapicetta, R. Monarca, L. A. Kondili, P. Chionne, M. E. Madeddu et al., Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy, Infection, vol.41, p.23264095, 2013.

C. Semaille, L. Strat, Y. Chiron, E. Chemlal, K. Valantin et al., Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy. Eurosurveillance. European Centre for Disease Prevention and Control, vol.18, p.23870097, 2013.

Y. Morice, D. Roulot, V. Grando, J. Stirnemann, E. Gault et al., Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns, J GenVirol, vol.82, p.11297675, 2001.

J. M. Mansuy, P. Gallian, C. Dimeglio, K. Saune, C. Arnaud et al., A nationwide survey of hepatitis E viral infection in French blood donors, Hepatology, vol.63, p.27008201, 2016.

J. Hartl, B. Otto, R. G. Madden, G. Webb, K. L. Woolson et al., Hepatitis E Seroprevalence in Europe: A Meta-Analysis. Viruses, vol.8, p.27509518, 2016.

C. Jacomet, A. Guyot-lé-nat, C. Bonny, C. Henquell, M. Rude et al., Addressing the challenges of chronic viral infections and addiction in prisons: the PRODEPIST study, Eur J Public Health, vol.26, pp.122-128, 2016.

K. Dolan, A. L. Wirtz, B. Moazen, M. Ndeffo-mbah, A. Galvani et al., Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees, Lancet, vol.388, pp.1089-1102, 2016.

P. Morlat, Prise en charge mé dicale des personnes vivant avec le VIH: recommandations du groupe d'experts, 2017.

C. Meffre, L. Strat, Y. Delarocque-astagneau, E. Dubois, F. Antona et al., Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors, BMC Infect Dis, vol.82, p.29433454, 2010.

, Direction de l'Administration Pénitentiaire. Statistique mensuelle des personnes écroué es et détenues en France

S. Marques-nm-da, R. Margalho, M. J. Melo, J. Da-cunha, and A. A. Meliço-silvestre, Seroepidemiological survey of transmissible infectious diseases in a Portuguese prison establishment, Braz J Infect Dis, vol.15, p.21670930, 2011.

M. Zuin, C. Caserta, L. Romanò, A. Mele, A. Zanetti et al., Seroepidemiology of HEV and HAV in two populations with different socio-economic levels and hygienic/sanitary conditions, Eur J ClinMicrobiol Infect Dis, vol.36, p.27785638, 2017.